FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149208599> ?p ?o ?g. }

• W2149208599 endingPage "1918" @default.
• W2149208599 startingPage "1908" @default.
• W2149208599 abstract "Background. Although many studies have investigated the possible association between analgesic use (acetaminophen and aspirin) and the development of chronic kidney disease (CKD), the effect of analgesics on the progression of established CKD of any cause has not yet been investigated. Methods. In this population-based Swedish cohort study, we investigated the decline over 5–7 years in estimated glomerular filtration rate (eGFR) among 801 patients with incident, advanced CKD (serum creatinine >3.4 mg/dL for men, >2.8 mg/dL for women for the first time) and with different analgesic exposures. Lifetime analgesic use and current regular use were ascertained through in-person interviews at inclusion while data on analgesic use during the follow-up was abstracted from the medical records at the end of the study period. A linear regression slope, based on their eGFR values during the follow-up, provided a summary of within-individual change. In the final multivariate analyses, a linear mixed effects model was implemented to assess the relation of analgesic use and change in eGFR over time. Results. The progression rate for regular users of acetaminophen was slower than that for non-regular users (regular users progressed 0.93 mL/min/1.73 m 2 per year slower than non-regular users; 95% CI 0.03, 1.8). For regular users of aspirin, the progression rate was significantly slower than that for non-regular users (regular users progressed 0.80 mL/min/1.73 m 2 per year slower than non-regular users; 95% CI 0.1, 1.5). Different levels of lifetime cumulative dose of acetaminophen and aspirin did not significantly affect the progression rate. Conclusion. We suggest that single substance acetaminophen and aspirin may be safe to use by patients with diagnosed advanced CKD stage 4–5 without an adverse effect on the progression rate of the disease." @default.
• W2149208599 created "2016-06-24" @default.
• W2149208599 creator A5009047728 @default.
• W2149208599 creator A5022613340 @default.
• W2149208599 creator A5023388139 @default.
• W2149208599 creator A5038606088 @default.
• W2149208599 creator A5040457003 @default.
• W2149208599 creator A5053734740 @default.
• W2149208599 creator A5055526341 @default.
• W2149208599 creator A5077710831 @default.
• W2149208599 date "2009-01-20" @default.
• W2149208599 modified "2023-10-09" @default.
• W2149208599 title "Acetaminophen, aspirin and progression of advanced chronic kidney disease" @default.
• W2149208599 cites W1967070195 @default.
• W2149208599 cites W1976785116 @default.
• W2149208599 cites W1981282933 @default.
• W2149208599 cites W2000445173 @default.
• W2149208599 cites W2035841461 @default.
• W2149208599 cites W2046933619 @default.
• W2149208599 cites W2049657688 @default.
• W2149208599 cites W2053744224 @default.
• W2149208599 cites W2055864845 @default.
• W2149208599 cites W2057523505 @default.
• W2149208599 cites W2057584124 @default.
• W2149208599 cites W2061379059 @default.
• W2149208599 cites W2061951662 @default.
• W2149208599 cites W2063210769 @default.
• W2149208599 cites W2075391935 @default.
• W2149208599 cites W2088469146 @default.
• W2149208599 cites W2089667862 @default.
• W2149208599 cites W2098796476 @default.
• W2149208599 cites W2099793887 @default.
• W2149208599 cites W2112735212 @default.
• W2149208599 cites W2114019720 @default.
• W2149208599 cites W2122158655 @default.
• W2149208599 cites W2136670164 @default.
• W2149208599 cites W2137404037 @default.
• W2149208599 cites W2140452679 @default.
• W2149208599 cites W2147804563 @default.
• W2149208599 cites W2158083031 @default.
• W2149208599 cites W2320758398 @default.
• W2149208599 cites W2337559048 @default.
• W2149208599 cites W4231383907 @default.
• W2149208599 cites W4245980853 @default.
• W2149208599 doi "https://doi.org/10.1093/ndt/gfn745" @default.
• W2149208599 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19155536" @default.
• W2149208599 hasPublicationYear "2009" @default.
• W2149208599 type Work @default.
• W2149208599 sameAs 2149208599 @default.
• W2149208599 citedByCount "48" @default.
• W2149208599 countsByYear W21492085992012 @default.
• W2149208599 countsByYear W21492085992013 @default.
• W2149208599 countsByYear W21492085992014 @default.
• W2149208599 countsByYear W21492085992015 @default.
• W2149208599 countsByYear W21492085992016 @default.
• W2149208599 countsByYear W21492085992017 @default.
• W2149208599 countsByYear W21492085992018 @default.
• W2149208599 countsByYear W21492085992019 @default.
• W2149208599 countsByYear W21492085992020 @default.
• W2149208599 countsByYear W21492085992021 @default.
• W2149208599 countsByYear W21492085992022 @default.
• W2149208599 countsByYear W21492085992023 @default.
• W2149208599 crossrefType "journal-article" @default.
• W2149208599 hasAuthorship W2149208599A5009047728 @default.
• W2149208599 hasAuthorship W2149208599A5022613340 @default.
• W2149208599 hasAuthorship W2149208599A5023388139 @default.
• W2149208599 hasAuthorship W2149208599A5038606088 @default.
• W2149208599 hasAuthorship W2149208599A5040457003 @default.
• W2149208599 hasAuthorship W2149208599A5053734740 @default.
• W2149208599 hasAuthorship W2149208599A5055526341 @default.
• W2149208599 hasAuthorship W2149208599A5077710831 @default.
• W2149208599 hasBestOaLocation W21492085991 @default.
• W2149208599 hasConcept C126322002 @default.
• W2149208599 hasConcept C159641895 @default.
• W2149208599 hasConcept C2777628954 @default.
• W2149208599 hasConcept C2778653478 @default.
• W2149208599 hasConcept C2778722691 @default.
• W2149208599 hasConcept C2780306776 @default.
• W2149208599 hasConcept C2780820201 @default.
• W2149208599 hasConcept C2908647359 @default.
• W2149208599 hasConcept C42219234 @default.
• W2149208599 hasConcept C71924100 @default.
• W2149208599 hasConcept C72563966 @default.
• W2149208599 hasConcept C99454951 @default.
• W2149208599 hasConceptScore W2149208599C126322002 @default.
• W2149208599 hasConceptScore W2149208599C159641895 @default.
• W2149208599 hasConceptScore W2149208599C2777628954 @default.
• W2149208599 hasConceptScore W2149208599C2778653478 @default.
• W2149208599 hasConceptScore W2149208599C2778722691 @default.
• W2149208599 hasConceptScore W2149208599C2780306776 @default.
• W2149208599 hasConceptScore W2149208599C2780820201 @default.
• W2149208599 hasConceptScore W2149208599C2908647359 @default.
• W2149208599 hasConceptScore W2149208599C42219234 @default.
• W2149208599 hasConceptScore W2149208599C71924100 @default.
• W2149208599 hasConceptScore W2149208599C72563966 @default.
• W2149208599 hasConceptScore W2149208599C99454951 @default.
• W2149208599 hasIssue "6" @default.
• W2149208599 hasLocation W21492085991 @default.

• next